Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
Annals of Surgery|June 30, 2016
Postoperative 30-day Readmission: Time to Focus on What Happens Outside the HospitalMelanie S Morris, Laura A Graham, Joshua S Richman, et al.
Nature Immunology|April 18, 2018
c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cellsLeona Gabryšová, Marisol Alvarez-Martinez, Raphaëlle Luisier, et al.
Nature Immunology|February 9, 2019
Publisher Correction: c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cellsLeona Gabryšová, Marisol Alvarez-Martinez, Raphaëlle Luisier, et al.
Particle and Fibre Toxicology|June 13, 2026
Inhalation exposure to surrogate military burn pit emissions impairs systemic microvascular function: linking pulmonary insult and diverse peripheral responsesVan Nguyen, Anand Ranpara, William T Goldsmith, et al.
Frontiers in Microbiology|June 20, 2015
Phylogenomics of Xanthomonas field strains infecting pepper and tomato reveals diversity in effector repertoires and identifies determinants of host specificityAllison R Schwartz, Neha Potnis, Sujan Timilsina, et al.
Systematic Reviews|July 11, 2015
Advancing the field of health systems research synthesisEtienne V Langlois, Michael K Ranson, Till Bärnighausen, et al.
BMJ Open|December 9, 2023
Specialist healthcare services for concussion/mild traumatic brain injury in England: a consensus statement using modified Delphi methodologyElika Karvandi, Adel Helmy, Angelos G Kolias, et al.
BMJ Open|June 17, 2024
Cost-effectiveness of craniotomy versus decompressive craniectomy for UK patients with traumatic acute subdural haematomaSarah Pyne, Garry Barton, David Turner, et al.
BMJ Open|December 8, 2021
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetesCharlotte S Wilhelm-Benartzi, Sarah E Miller, Sylvaine Bruggraber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2020
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure CharacteristicsTimothy Papaluca, Stuart K Roberts, Simone I Strasser, et al.
Pageof 32